We analyzed a database of 243 patients with endometrioid tumors of the ovary treated with first line Pt/taxane chemotherapy and found that patients with high hCtr1 levels, but not ATP7A and ATP7B, have significantly longer progression-free survival (PFS) and OS than those with low hCtr1 [20]. The gene discussed is SLC31A1; the disease is ovarian endometrial cancer.